Unknown

Dataset Information

0

Administration of B7-H3 targeted chimeric antigen receptor-T cells induce regression of glioblastoma.

ABSTRACT:

SUBMITTER: Tang X 

PROVIDER: S-EPMC7994554 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres.
| S-EPMC6796553 | biostudies-literature
Unknown Bioactivity and safety of B7?H3?targeted chimeric antigen receptor T cells against anaplastic meningioma.
| S-EPMC7292833 | biostudies-literature
Unknown Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy.
| S-EPMC5390684 | biostudies-literature
Unknown B7-H3 Chimeric Antigen Receptor Redirected T Cells Target Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma.
| S-EPMC7766167 | biostudies-literature
Unknown Preclinical Evaluation of B7-H3-specific Chimeric Antigen Receptor T Cells for the Treatment of Acute Myeloid Leukemia.
| S-EPMC8248479 | biostudies-literature
Unknown Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes.
| S-EPMC7844995 | biostudies-literature
Unknown Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells.
| S-EPMC6645919 | biostudies-literature
Unknown B7-H3 specific T cells with chimeric antigen receptor and decoy PD-1 receptors eradicate established solid human tumors in mouse models.
| S-EPMC6959446 | biostudies-literature
Unknown B7-H3-targeted Radioimmunotherapy of Human Cancer.
| S-EPMC8668195 | biostudies-literature
Unknown Engineering Chimeric Antigen Receptor T cells to Treat Glioblastoma.
| S-EPMC5695679 | biostudies-literature